{"id":"NCT01139021","sponsor":"Novartis Vaccines","briefTitle":"One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of Age","officialTitle":"A Phase 3, Open-Label, Multi-Center, Extension Study of V72P13E1 to Assess Antibody Persistence at One Year After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting at 12 Months of Age and to Evaluate the Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2010-11","completion":"2011-09","firstPosted":"2010-06-08","resultsPosted":"2015-04-10","lastUpdate":"2015-04-10"},"enrollment":508,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"rMenB+OMV NZ","otherNames":[]}],"arms":[{"label":"B246_12_M12","type":"EXPERIMENTAL"},{"label":"B246_12M13","type":"EXPERIMENTAL"},{"label":"B13_15_27","type":"EXPERIMENTAL"},{"label":"B12_14_26","type":"EXPERIMENTAL"},{"label":"B_24_26","type":"EXPERIMENTAL"},{"label":"B12M13","type":"EXPERIMENTAL"}],"summary":"One year antibody persistence after the fourth dose boost or two catch-up doses administered starting from 12 months of age and to evaluate the response to a a third dose boost or two catch-up dose starting at 24 months of age.","primaryOutcome":{"measure":"Geometric Mean Titers (GMTs) to Assess Antibody Persistence at 12 Months After a Booster Dose of rMenB+OMV NZ Vaccination.","timeFrame":"12 months post booster (fourth) vaccination.","effectByArm":[{"arm":"B246_12M12","deltaMin":7.38,"sd":null},{"arm":"B246_12M13","deltaMin":8.3,"sd":null},{"arm":"B246_12Tot","deltaMin":6.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"23 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":10,"exclusionCount":18},"locations":{"siteCount":19,"countries":["Czechia","Finland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":67},"commonTop":["Injection Site Pain","Injection Site Erythema","Irritability","Injection Site Swelling","Somnolence"]}}